Quality of life of patients with rheumatic diseases during the COVID-19 pandemic : The biopsychosocial path

BACKGROUND: Previous models that assess quality-of-Life (QoL) in patients with rheumatic diseases have a strong biomedical focus. We evaluated the impact of COVID-19 related-health care interruption (HCI) on the physical, psychological, social relationships and environment QoL-dimensions, and explored factors associated with QoL when patients were reincorporated to the outpatient clinic, and after six-month follow-up.

PATIENTS AND METHODS: Study phase-1 consisted of a COVID-19 survey administered from June 24th-October 31st 2020, to outpatients with rheumatic diseases who had face-to-face consultation at outpatient clinic reopening. Study phase-2 consisted of 3 consecutive assessments of patient´s QoL (WHOQOL-BREF), disease activity/severity (RAPID-3), and psychological comorbidity/trauma (DASS-21 and IES-R) to patients from phase-1 randomly selected. Sociodemographic, disease and treatment-related information, and comorbidities were obtained. Multiple linear regression analysis identified factors associated with the score assigned to each WHOQOL-BREF dimension.

RESULTS: Patients included (670 for phase-1 and 276 for phase-2), had primarily SLE and RA (44.2% and 34.1%, respectively), and all the dimensions of their WHOQOL-BREF were affected. There were 145 patients (52.5%) who referred HCI, and they had significantly lower dimensions scores (but the environment dimension score). Psycho-emotional factors (primarily feeling confused, depression and anxiety), sociodemographic factors (age, COVID-19 negative economic impact, years of scholarship, HCI and having a job), and biomedical factors (RAPID-3 score and corticosteroid use) were associated with baseline QoL dimensions scores. Psycho-emotional factors showed the strongest magnitude on dimensions scores. Most consistent predictor of six-month follow-up QoL dimensions scores was each corresponding baseline dimension score, while social determinants (years of scholarship and having a job), emotional factors (feeling bored), and biomedical aspects (RAPID 3) had an additional impact.

CONCLUSIONS: HCI impacted the majority of patient´s QoL dimensions. Psycho-emotional, sociodemographic and biomedical factors were consistently associated with QoL dimensions scores, and these consistently predicted the QoL trajectory.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:17

Enthalten in:

PloS one - 17(2022), 1 vom: 18., Seite e0262756

Sprache:

Englisch

Beteiligte Personen:

Guaracha-Basáñez, Guillermo A [VerfasserIn]
Contreras-Yáñez, Irazú [VerfasserIn]
Hernández-Molina, Gabriela [VerfasserIn]
Estrada-González, Viviana A [VerfasserIn]
Pacheco-Santiago, Lexli D [VerfasserIn]
Valverde-Hernández, Salvador S [VerfasserIn]
Galindo-Donaire, José Roberto [VerfasserIn]
Peláez-Ballestas, Ingris [VerfasserIn]
Pascual-Ramos, Virginia [VerfasserIn]

Links:

Volltext

Themen:

Clinical Trial
Journal Article

Anmerkungen:

Date Completed 24.01.2022

Date Revised 17.09.2023

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1371/journal.pone.0262756

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM335764134